Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Shoulder Innovations, Inc.NYSE: SI
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue grows, but more slowly than its trailing trend
Q1 FY2026 cost of revenue of $3.72M rose 23.7% year over year, behind the +53.2% change in trailing-twelve-month cost of revenue. Sequentially, it rose 10.8% from the prior quarter.
Context
- Cost of revenue amounted to 23.5% of revenue in FY2025, up 0.5 pp from a year earlier.
- Cost of revenue increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly growth recovers from +23.7% toward the trailing-twelve-month pace of +53.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 11.12M USD
- Year-over-year change
- +52.6%
- 2-year CAGR
- +66.6%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.12M | +52.6% |
| FY2024 | 2024-12-31 | 7.28M | +81.9% |
| FY2023 | 2023-12-31 | 4M | — |
Cost of Revenue vs competitors
How SI compares with its peers on the latest reported figures
- SI's LTM Mar 2026 cost of revenue of $13.21M is the 6th highest of the 11 companies compared; the peer median is $13.48M.
- Its year-over-year change of +53.2% is the highest of 9, against a peer median of +6.0%.
- Cost of revenue amounts to 24.5% of revenue for SI, versus a peer median of 40.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $180.21M | -1.6% | -6.5% | 51.3% | |
| LTM Mar 2026 | $69.8M | -5.5% | -9.3% | 59.4% | |
| FY2025 | $43.43M | +24.4% | +34.5% | 40.3% | |
| LTM Dec 2025 | $25.81M | +17.4% | +18.6% | 198.2% | |
| LTM Mar 2026 | $16.18M | -62.1% | -87.7% | 22.8% | |
| LTM Mar 2026 | $13.21M | +53.2% | — | 24.5% | |
| LTM Mar 2026 | $10.78M | +27.5% | +32.5% | 24.3% | |
| LTM Mar 2026 | $6.32M | -43.5% | +23.7% | — | |
| LTM Mar 2026 | $1.21M | — | — | 1.7% | |
EPRXEupraxia Pharmaceuticals Inc. | LTM Mar 2026 | $151.18K | +13.6% | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding SI) | $13.48M | +6.0% | +18.6% | 40.3% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 19.27M | 31.62M | 47.32M |
| Cost of Revenue | 4M | 7.28M | 11.12M |
| Gross Profit | 15.27M | 24.34M | 36.2M |
| Gross Margin | 79.2% | 77.0% | 76.5% |
| Research & Development | 3.02M | 4.49M | 7.73M |
| Selling, General & Admin | 23.11M | 34.51M | 54.77M |
| Operating Expenses | 26.13M | 38.99M | 62.5M |
| Depreciation & Amortization | 1.64M | 2.2M | 3.21M |
| EBITDA | (10.25M) | (12.11M) | (37.08M) |
| EBITDA Margin | -53.2% | -38.3% | -78.4% |
| Operating Income | (10.86M) | (14.65M) | (26.3M) |
| Operating Margin | -56.4% | -46.3% | -55.6% |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 761K | 1.32M | 70K |
| Other Income / Expenses | (1.79M) | (966K) | (14.06M) |
| Income Before Tax | (12.66M) | (15.62M) | (40.36M) |
| Pre-Tax Margin | -65.7% | -49.4% | -85.3% |
| Income Tax Expense | 0 | 0 | 0 |
| Net Income | (12.66M) | (15.62M) | (40.36M) |
| Net Margin | -65.7% | -49.4% | -85.3% |
| EPS (Basic) | (0.63) | (0.77) | (1.96) |
| EPS (Diluted) | (0.63) | (0.77) | (1.96) |
| Weighted Avg Shares | 19.92M | 19.92M | 20.63M |
| Weighted Avg Shares (Diluted) | 19.92M | 19.92M | 20.63M |
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.